{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T04:23:08Z","timestamp":1728447788788},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,1,31]],"date-time":"2011-01-31T00:00:00Z","timestamp":1296432000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2011,1,31]],"date-time":"2011-01-31T00:00:00Z","timestamp":1296432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Selecting women affected with breast cancer who are most likely to carry a germline mutation in <jats:italic>BRCA1<\/jats:italic> and applying the most appropriate test methodology remains challenging for cancer genetics services. We sought to test the value of selecting women for <jats:italic>BRCA1<\/jats:italic> mutation testing on the basis of family history and\/or breast tumour morphology criteria as well as the value of testing for large genomic alterations in <jats:italic>BRCA1<\/jats:italic> .<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>We studied women participating in the Breast Cancer Family Registry (BCFR), recruited via population-based sampling, who had been diagnosed with breast cancer before the age of 40 years who had a strong family history of breast or ovarian cancer (<jats:italic>n<\/jats:italic> = 187) and\/or a first primary breast tumour with morphological features consistent with carrying a <jats:italic>BRCA1<\/jats:italic> germline mutation (<jats:italic>n<\/jats:italic> = 133; 37 met both criteria). An additional 184 women diagnosed before the age of 40 years who had a strong family history of breast or ovarian cancer and who were not known to carry a germline <jats:italic>BRCA1<\/jats:italic> mutation were selected from among women who had been recruited into the BCFR from clinical genetics services. These 467 women had been screened for <jats:italic>BRCA1<\/jats:italic> germline mutations, and we expanded this testing to include a screen for large genomic <jats:italic>BRCA1<\/jats:italic> alterations using Multiplex Ligation-dependent Probe Amplification.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Twelve large genomic <jats:italic>BRCA1<\/jats:italic> alterations were identified, including 10 (4%) of the 283 women selected from among the population-based sample. In total, 18 (12%), 18 (19%) and 16 (43%) <jats:italic>BRCA1<\/jats:italic> mutations were identified in the population-based groups selected on the basis of family history only (<jats:italic>n<\/jats:italic> = 150), the group selected on the basis of tumour morphology only (<jats:italic>n<\/jats:italic> = 96) and meeting both criteria (<jats:italic>n<\/jats:italic> = 37), respectively.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Large genomic alterations accounted for 19% of all <jats:italic>BRCA1<\/jats:italic> mutations identified. This study emphasises the value of combining information about family history, age at diagnosis and tumour morphology when selecting women for germline <jats:italic>BRCA1<\/jats:italic> mutation testing as well as including a screen for large genomic alterations.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/bcr2822","type":"journal-article","created":{"date-parts":[[2011,2,22]],"date-time":"2011-02-22T19:17:12Z","timestamp":1298402232000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry"],"prefix":"10.1186","volume":"13","author":[{"given":"Letitia D","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea A","family":"Tesoriero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ee M","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan J","family":"Ramus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances P","family":"O'Malley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Marie","family":"Mulligan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Beth","family":"Terry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruby T","family":"Senie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina M","family":"Santella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther M","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene L","family":"Andrulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilmi","family":"Ozcelik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary B","family":"Daly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew K","family":"Godwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saundra S","family":"Buys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E","family":"Goldgar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham G","family":"Giles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John L","family":"Hopper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa C","family":"Southey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,1,31]]},"reference":[{"key":"2629_CR1","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/sj.bjc.6604305","volume":"98","author":"AC Antoniou","year":"2008","unstructured":"Antoniou AC, Cunningham AP, Peto J, Evans DG, Lalloo F, Narod SA, Risch HA, Eyfjord JE, Hopper JL, Southey MC, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tryggvadottir L, Syrjakoski K, Kallioniemi OP, Eerola H, Nevanlinna H, Pharoah PD, et al: The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer. 2008, 98: 1457-1466. 10.1038\/sj.bjc.6604305.","journal-title":"Br J Cancer"},{"key":"2629_CR2","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1200\/JCO.2002.09.023","volume":"20","author":"S Lakhani","year":"2002","unstructured":"Lakhani S, van de Vijver MJ, Jacquemier J, Anderson TJ, Osin PP, McGuffog L, Easton DF, for the Breast Cancer Linkage Consortium: The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2 . J Clin Oncol. 2002, 20: 2310-2318. 10.1200\/JCO.2002.09.023.","journal-title":"J Clin Oncol"},{"key":"2629_CR3","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1200\/JCO.2005.01.9737","volume":"24","author":"PA James","year":"2006","unstructured":"James PA, Doherty R, Harris M, Mukesh BN, Milner A, Young MA, Scott C: Optimal selection of individuals for BRCA mutation testing: a comparison of available methods. J Clin Oncol. 2006, 24: 707-715. 10.1200\/JCO.2005.01.9737.","journal-title":"J Clin Oncol"},{"key":"2629_CR4","doi-asserted-by":"publisher","first-page":"R28","DOI":"10.1186\/bcr2576","volume":"12","author":"N Mavaddat","year":"2010","unstructured":"Mavaddat N, Rebbeck TR, Lakhani SR, Easton DF, Antoniou AC: Incorporating tumour pathology information into breast cancer risk prediction algorithms. Breast Cancer Res. 2010, 12: R28-10.1186\/bcr2576.","journal-title":"Breast Cancer Res"},{"key":"2629_CR5","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1002\/(SICI)1097-0142(19981201)83:11<2335::AID-CNCR13>3.0.CO;2-N","volume":"83","author":"JE Armes","year":"1998","unstructured":"Armes JE, Egan AJM, Southey MC, Dite GS, McCredie MRE, Giles GG, Hopper JL, Venter DJ: The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 and BRCA2 germline mutations: a population-based study. Cancer. 1998, 83: 2335-2345. 10.1002\/(SICI)1097-0142(19981201)83:11<2335::AID-CNCR13>3.0.CO;2-N.","journal-title":"Cancer"},{"key":"2629_CR6","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/jnci\/90.15.1138","volume":"90","author":"S Lakhani","year":"1998","unstructured":"Lakhani S, Jacquemier J, Sloane JP, Gusterson BA, Anderson TJ, van de Vijver MJ, Farid LM, Venter D, Antoniou A, Storfer-Isser A, Smyth E, Steel CM, Haites N, Scott RJ, Goldgar D, Neuhausen S, Daly PA, Ormiston W, McManus R, Scherneck S, Ponder BA, Ford D, Peto J, Stoppa-Lyonnet D, Bignon YJ, Struewing JP, Spurr NK, Bishop DT, Klijn JG, Devilee P, et al: Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst. 1998, 90: 1138-45. 10.1093\/jnci\/90.15.1138.","journal-title":"J Natl Cancer Inst"},{"key":"2629_CR7","volume-title":"Br J Cancer","author":"MC Southey","year":"2011","unstructured":"Southey MC, Ramus SJ, Dowty JG, Smith LD, Tesoriero AA, Wong EE, Dite GS, Jenkins MA, Byrnes GB, Winship I, Phillips KA, Giles GG, Hopper JL: Morphological predictors of BRCA1 germline mutations in young women with breast cancer. Br J Cancer. 2011,"},{"key":"2629_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/humu.10097","volume":"20","author":"IL Andrulis","year":"2002","unstructured":"Andrulis IL, Anton-Culver H, Beck J, Bove B, Boyd J, Buys S, Goodwin AK, Hopper JL, Li F, Neuhausen SL, Ozcelik H, Peel D, Santella RM, Southey MC, van Orsouw NJ, Venter DJ, Vijg J, Whittemore AS: Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations. Hum Mutat. 2002, 20: 65-73. 10.1002\/humu.10097.","journal-title":"Hum Mutat"},{"key":"2629_CR9","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/humu.20896","volume":"29","author":"SV Tavtigian","year":"2008","unstructured":"Tavtigian SV, Byrnes GB, Goldgar DE, Thomas A: Classification of rare missense substitutions, using risk surfaces, with genetic- and molecular-epidemiology applications. Hum Mutat. 2008, 29: 1342-1354. 10.1002\/humu.20896.","journal-title":"Hum Mutat"},{"key":"2629_CR10","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1002\/humu.20892","volume":"29","author":"SV Tavtigian","year":"2008","unstructured":"Tavtigian SV, Greenblatt MS, Lesueur F, Byrnes GB, IARC Unclassified Genetic Variants Working Group: In silico analysis of missense substitutions using sequence-alignment based methods. Hum Mutat. 2008, 29: 1327-1336. 10.1002\/humu.20892.","journal-title":"Hum Mutat"},{"key":"2629_CR11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10549-010-0817-z","volume":"125","author":"MD Sluiter","year":"2011","unstructured":"Sluiter MD, van Rensburg EJ: Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation. Breast Cancer Res Treat. 2011, 125: 325-349. 10.1007\/s10549-010-0817-z.","journal-title":"Breast Cancer Res Treat"},{"key":"2629_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10549-010-0745-y","volume":"124","author":"I Ticha","year":"2010","unstructured":"Ticha I, Kleibl Z, Stribrna J, Kotlas J, Zimovjanova M, Mateju M, Zikan M, Pohlreich P: Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast\/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene. Breast Cancer Res Treat. 2010, 124: 337-347. 10.1007\/s10549-010-0745-y.","journal-title":"Breast Cancer Res Treat"},{"key":"2629_CR13","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/gcc.20342","volume":"45","author":"S Agata","year":"2006","unstructured":"Agata S, Viel A, Della Puppa L, Cortesi L, Fersini G, Callegaro M, Dalla Palma M, Dolcetti R, Federico M, Venuta S, Miolo G, D'Andrea E, Montagna M: Prevalence of BRCA1 genomic rearrangements in a large cohort of Italian breast and breast\/ovarian cancer families without detectable BRCA1 and BRCA2 point mutations. Genes Chromosomes Cancer. 2006, 45: 791-797. 10.1002\/gcc.20342.","journal-title":"Genes Chromosomes Cancer"},{"key":"2629_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/ng1197-341","volume":"17","author":"A Petrij-Bosch","year":"1997","unstructured":"Petrij-Bosch A, Peelen T, van Vliet M, van Eijk R, Olmer R, Dr\u00fcsedau M, Hogervorst FB, Hageman S, Arts PJ, Ligtenberg MJ, Meijers-Heijboer H, Klijn JG, Vasen HF, Cornelisse CJ, van't Veer LJ, Bakker E, van Ommen GJ, Devilee P: BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet. 1997, 17: 341-345. 10.1038\/ng1197-341.","journal-title":"Nat Genet"},{"key":"2629_CR15","first-page":"1449","volume":"63","author":"FB Hogervorst","year":"2003","unstructured":"Hogervorst FB, Nederlof PM, Gille JJ, McElgunn CJ, Grippeling M, Pruntel R, Regnerus R, van Welsem T, van Spaendonk R, Menko FH, Kluijt I, Dommering C, Verhoef S, Schouten JP, van't Veer LJ, Pals G: Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res. 2003, 63: 1449-1453.","journal-title":"Cancer Res"},{"key":"2629_CR16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1089\/gtmb.2008.0155","volume":"13","author":"AM Van den Ouweland","year":"2009","unstructured":"Van den Ouweland AM, Dinjens WN, Dorssers LC, van Veghel-Plandsoen MM, Br\u00fcggenwirth HT, Withagen-Hermans CJ, Coll\u00e9e JM, Joosse SA, Terlouw-Kromosoeto JN, Nederlof PM: Deletion of exons 1a-2 of BRCA1 : a rather frequent pathogenic abnormality. Genet Test Mol Biomarkers. 2009, 13: 399-406. 10.1089\/gtmb.2008.0155.","journal-title":"Genet Test Mol Biomarkers"},{"key":"2629_CR17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10549-008-0153-8","volume":"116","author":"SL Neuhausen","year":"2009","unstructured":"Neuhausen SL, Ozcelik H, Southey MC, John EM, Godwin AK, Chung W, Iriondo-Perez J, Miron A, Santella RM, Whittemore A, Andrulis IL, Buys SS, Daly MB, Hopper JL, Seminara D, Senie RT, Terry MB, Breast Cancer Family Registry: BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research. Breast Cancer Res Treat. 2009, 116: 379-386. 10.1007\/s10549-008-0153-8.","journal-title":"Breast Cancer Res Treat"},{"key":"2629_CR18","doi-asserted-by":"publisher","first-page":"R375","DOI":"10.1186\/bcr801","volume":"6","author":"EM John","year":"2004","unstructured":"John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, Ziogas A, Andrulis IL, Anton-Culver H, Boyd N, Buys SS, Daly MB, O'Malley FP, Santella RM, Southey MC, Venne VL, Venter DJ, West DW, Whittemore AS, Seminara D, Breast Cancer Family Registry: The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res. 2004, 6: R375-R389. 10.1186\/bcr801.","journal-title":"Breast Cancer Res"},{"key":"2629_CR19","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/jnci\/95.6.448","volume":"95","author":"GS Dite","year":"2003","unstructured":"Dite GS, Jenkins MA, Southey MC, Hocking JS, Giles GG, McCredie MR, Venter DJ, Hopper JL: Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. J Natl Cancer Inst. 2003, 95: 448-457. 10.1093\/jnci\/95.6.448.","journal-title":"J Natl Cancer Inst"},{"key":"2629_CR20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/94.3.205","volume":"94","author":"G Chenevix-Trench","year":"2002","unstructured":"Chenevix-Trench G, Spurdle AB, Gatei M, Kelly H, Marsh A, Chen X, Donn K, Cummings M, Nyholt D, Jenkins MA, Scott C, Pupo GM, D\u00f6rk T, Bendix R, Kirk J, Tucker K, McCredie MR, Hopper JL, Sambrook J, Mann GJ, Khanna KK: Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst. 2002, 94: 205-215.","journal-title":"J Natl Cancer Inst"},{"key":"2629_CR21","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/humu.20415","volume":"27","author":"JL Bernstein","year":"2006","unstructured":"Bernstein JL, Teraoka S, Southey MC, Jenkins MA, Andrulis IL, Knight JA, John EM, Lapinski R, Wolitzer AL, Whittemore AS, West D, Seminara D, Olson ER, Spurdle AB, Chenevix-Trench G, Giles GG, Hopper JL, Concannon P: Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry. Hum Mutat. 2006, 27: 1122-1128. 10.1002\/humu.20415.","journal-title":"Hum Mutat"},{"key":"2629_CR22","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.1158\/0008-5472.CAN-09-0851","volume":"70","author":"J Mouchawar","year":"2010","unstructured":"Mouchawar J, Korch C, Byers T, Pitts TM, Li E, McCredie MR, Giles GG, Hopper JL, Southey MC: Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study. Cancer Res. 2010, 70: 4795-4800. 10.1158\/0008-5472.CAN-09-0851.","journal-title":"Cancer Res"},{"key":"2629_CR23","unstructured":"Breast Cancer Information Core. [http:\/\/research.nhgri.nih.gov\/bic\/]"},{"key":"2629_CR24","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S0360-3016(00)00728-8","volume":"48","author":"T Leong","year":"2000","unstructured":"Leong T, Whitty J, Keilar M, Mifsud S, Ramsay J, Birrell G, Venter D, Southey M, McKay M: Mutation analysis of BRCA1 and BRCA2 cancer predisposition genes in radiation hypersensitive cancer patients. Int J Radiat Oncol Biol Phys. 2000, 48: 959-965. 10.1016\/S0360-3016(00)00728-8.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2629_CR25","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1093\/nar\/gnf056","volume":"30","author":"JP Schouten","year":"2002","unstructured":"Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G: Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 2002, 30: e57-10.1093\/nar\/gnf056.","journal-title":"Nucleic Acids Res"},{"key":"2629_CR26","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.ejca.2007.01.011","volume":"43","author":"LD Smith","year":"2007","unstructured":"Smith LD, Tesoriero AA, Ramus SJ, Dite G, Royce SG, Giles GG, McCredie MRE, Hopper JL, Southey MC: BRCA1 promoter deletions in young women with breast cancer and a strong family history: a population-based study. Eur J Cancer. 2007, 43: 823-827. 10.1016\/j.ejca.2007.01.011.","journal-title":"Eur J Cancer"},{"key":"2629_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/modpathol.3800496","volume":"19","author":"TA Longacre","year":"2006","unstructured":"Longacre TA, Ennis M, Quenneville LA, Bane AL, Bleiweiss IJ, Carter BA, Catelano E, Hendrickson MR, Hibshoosh H, Layfield LJ, Memeo L, Wu H, O'Malley FP: Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study. Mod Pathol. 2006, 19: 195-207. 10.1038\/modpathol.3800496.","journal-title":"Mod Pathol"},{"key":"2629_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/sj.bjc.6690008","volume":"79","author":"MC Southey","year":"1999","unstructured":"Southey MC, Tesoriero AA, Andersen CR, Jennings KM, Brown SM, Dite GS, Jenkins MA, Osborne RH, Maskiell JA, Porter L, Giles GG, McCredie MR, Hopper JL, Venter DJ: BRCA1 mutations and other sequence variants in a population based sample of Australian women with breast cancer. Br J Cancer. 1999, 79: 34-39. 10.1038\/sj.bjc.6690008.","journal-title":"Br J Cancer"},{"key":"2629_CR29","first-page":"741","volume":"8","author":"JL Hopper","year":"1999","unstructured":"Hopper JL, Southey MC, Dite GS, Jolley DJ, Giles GG, McCredie MR, Easton DF, Venter DJ, Australian Breast Cancer Family Study: Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2 . Cancer Epidemiol Biomarkers Prev. 1999, 8: 741-747.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2629_CR30","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1136\/jmg.40.8.e91","volume":"40","author":"H Ozcelik","year":"2003","unstructured":"Ozcelik H, Knight JA, Glendon G, Yazici H, Carson N, Ainsworth PJ, Taylor SA, Feilotter H, Carter RF, Boyd NF, Andrulis IL, Ontario Cancer Genetics Network: Individual and family characteristics associated with protein truncating BRCA1 and BRCA2 mutations in an Ontario population based series from the Cooperative Family for Breast Cancer Studies. J Med Genet. 2003, 40: e91-10.1136\/jmg.40.8.e91.","journal-title":"J Med Genet"},{"key":"2629_CR31","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1136\/jmg.2005.032789","volume":"42","author":"S Agata","year":"2005","unstructured":"Agata S, Dalla Palma M, Callegaro M, Scaini MC, Menin C, Ghiotto C, Nicoletto O, Zavagno G, Chieco-Bianchi L, D'Andrea E, Montagna M: Large genomic deletions inactivate the BRCA2 gene in breast cancer families. J Med Genet. 2005, 42: e64-10.1136\/jmg.2005.032789.","journal-title":"J Med Genet"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr2822.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/bcr2822\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr2822.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:37:20Z","timestamp":1728383840000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr2822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,31]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2011,2]]}},"alternative-id":["2629"],"URL":"https:\/\/doi.org\/10.1186\/bcr2822","relation":{},"ISSN":["1465-542X"],"issn-type":[{"type":"electronic","value":"1465-542X"}],"subject":[],"published":{"date-parts":[[2011,1,31]]},"assertion":[{"value":"27 September 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R14"}}